ECM33 Antibody

Introduction to ECM33 Antibody

The ECM33 antibody targets the glycosylphosphatidylinositol (GPI)-anchored cell wall protein Ecm33 in C. albicans. This protein is essential for maintaining cell wall integrity (CWI), virulence, and stress adaptation . The antibody enables researchers to investigate Ecm33’s localization, expression, and interactions through techniques like immunoblotting and immunofluorescence .

Generation and Validation

The monoclonal ECM33 antibody (clone 2P11) was developed by immunizing rats with purified Ecm33 protein from Schizosaccharomyces pombe. Key validation steps include:

• Specificity: Immunoblotting confirmed reactivity with a 43.3-kDa protein in wild-type C. albicans, absent in ecm33Δ mutants .

• Localization: Immunofluorescence confirmed cell surface localization in yeast, hyphae, and biofilms .

• Applications: Validated for Western blotting, ELISA, and immunofluorescence microscopy .

Research Applications

Table 1: Key Research Applications of ECM33 Antibody

Key Research Findings

1. Cell Wall Defects: ecm33Δ mutants exhibit abnormal cell wall ultrastructure, including altered mannoprotein layers and hypersensitivity to stressors like calcofluor white .

2. Virulence Attenuation: Loss of ECM33 reduces fungal survival in mouse models and compromises host tissue invasion .

3. Morphogenesis: The antibody revealed aberrant Als1 adhesin localization in hyphae, linking Ecm33 to surface protein organization .

4. Secretory Pathway Role: Proteomic studies implicate Ecm33 in extracellular vesicle production and classical secretion pathways .

Limitations and Future Directions

While the ECM33 antibody has advanced our understanding of C. albicans biology, its exact molecular role remains unclear. Future studies could explore its interactions with TOR signaling pathways or its potential as a therapeutic target . Standardized validation across laboratories (per EuroMAbNet guidelines) will enhance reproducibility .